| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |